海外の治験の状況「1」での検索結果
1037件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
- Lung Cancer Non-small Cell Stage IV;C34 - Malignant neoplasm of bronchus and lung
- Austria, Belgium, Bulgaria, France, Germany, Ireland, Israel, Italy, Poland, Romania, Slovenia, Spain, Switzerland, United Kingdom
- 2016-01-26
Not recruiting
- Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma
- Melanoma
- Australia, Austria, Belgium, Finland, France, Germany, Ireland, Italy, Norway, Sweden, Switzerland, United Kingdom, United States
- 2015-11-05
Not recruiting
- Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
- Meningococcal Meninigitis, Serogroup C
- Austria, Germany
- 2005-09-08
Not recruiting
- Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
- Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Chile, Czech Republic, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom
- 2005-09-08
Not recruiting
- Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)
- Neoplasm Metastasis;Colorectal Cancer;Neoplasm Metastasis;Colorectal Cancer;Neoplasm Metastasis;Colorectal Cancer;Neoplasm Metastasis;Colorectal Cancer
- Austria, Belgium, France, Germany, Greece, Israel, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Ukraine
- 2005-07-28
Not recruiting
- A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
- Anemia
- Australia, Austria, Belgium, Canada, China, Czech Republic, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Poland, Spain
- 2006-05-16
Not Recruiting
- A multicenter, randomized, open-label dose finding study of RO0503821 in anemic patients with stage IIIB or IV non-small cell lung cancer receiving first line myelosuppressive chemotherapy
- Anemic patients undergoing chemotherapy
- Austria, Czech Republic, Estonia, Finland, Germany, Greece, Hungary, Italy, Spain
- 2006-01-18
Not Recruiting
- A randomized, open-label Phase III study to assess efficacy and safety of bevacizumab in combination with capecitabine as first line treatment for elderly patients with metastatic colorectal cancer - AVEX: AVastin in the Elderly with Xeloda
- First line metastatic colorectal carcinoma br>MedDRA version: 8.1 Level: LLT Classification code 10052358 Term: Colorectal cancer metastatic ;First line metastatic colorectal carcinoma br>MedDRA version: 8.1 Level: LLT Classification code 10052358 Term: Colorectal cancer metastatic
- Austria, Greece, Hungary, Italy, Netherlands, Poland, Slovenia, Spain, United Kingdom
- 2007-01-18
Not Recruiting
- Open-label study of bevacizumab (AVASTIN®) in combination with platinum-containing chemotherapy as first-line treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer - SAIL
- Advanced or recurrent non-squamous non-small cell lung cancer MedDRA version: 9 Level: PT Classification code 10059515
- Austria, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Iceland, Italy, Latvia, Lithuania, Netherlands, Portugal, Slovenia, Spain, Sweden, United Kingdom
- 2006-06-20
Not recruiting
- A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
- Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
- Australia, Austria, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Norway, Panama, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2003-09-15